Canadian Adverse Drug Reaction Newsletter: Zidovudine (AZT) Use during pregnancy decreases vertical transmission of HIV.


    loading  Checking for direct PDF access through Ovid

Abstract

To assist in the surveillance of adverse effects of this therapy, pregnant women who have received AZT should be enrolled in the Canadian arm of the international Antiretroviral Pregnancy Registry at 1-800-361-9686. To ensure more complete followup, however, physicians are welcome to submit confidential case reports to the Adverse Drug Reaction Monitoring Program. With permission, the necessary information will be extracted from the case report and communicated to the registry on behalf of the reporting physician.

    loading  Loading Related Articles